Nandan Biomatrix—Tapping nature for biofuels, nutraceuticals and aphrodisiacs

Dedicated to the cultivation, discovery, research and development of biofuels and medicinal plants, Nandan Biomatrix explores the vast potential in Nature. The company has a decade of experience in nutraceuticals with expertise in manufacturing standardised herbal extracts and lifestyle and healthcare products. Its unique integrated business model encompasses cultivation, R&D, processing, extraction, formulations, manufacturing and marketing of natural products. Nandan is determined to produce and market these unique products with effective therapeutic content duly standardised, differentiating Nandan from other players in the market and is expected to create a niche position for the company in the nutraceutical segment. Nandan's credibility is supported by high-end technology and excellent agricultural practices. Ensuring that all herbal products with high concentration of therapeutic value meet customised demands worldwide and provide genuine health and well-being products. Indicating the advantage Nandan accommodates with its vast cultivation and well managed captive farms of medicinal plants which are having control on standards. During the last fiscal 2007-08 the company generated Rs 74 crore and for the current financial year it is targeting to touch Rs 143 crore.

Recent developments

According to Indra Reddy, Product Manager, Nandan Biomatix, "We have launched a well researched product Bio-Rhythm in the Hyderabad market. Bio-Rhythm is natural aphrodisiac that fills the gap in the management of male sexual dysfunctions. The present era, men are under more pressure than ever before and the Bio-Rhythm is found to increase libido, reduce stress and improve energy." The safety studies of Bio-Rhythm reveal that Bio-Rhythm is safe for human consumption and suitable for long term usage. Nutritional study reveals that Bio-Rhythm is rich in zinc and other herbal constituents which, in turn, promote production of testosterone by the body naturally and protect sperm from free radical damage, thereby rejuvenating the body. The launch would be followed by similar launches across metros across India.

Work sites

The company has its manufacturing facility at Hyderabad and it is expanding its existing capacity. The current capacity is of 10 MT/ per month, with various herbs like Aloe Vera (40 percent), Safed Musli (40 percent); other herbs (20 percent). The company has total manpower strength of 250 people and plans to add more people in the near future.

Exploring new markets

The company has appointed distributors and submitted dossiers for registration in ASEAN countries, Cote D'Ivoire and expected to get marketing authorisations soon. Currently, it has four products for domestic and international markets. "We have 12 products in the pipeline, which are expected to complete R&D work and clinical safety studies in a phase wise manner. The therapeutic areas are male and female aphrodisiacs, male reproductive ailments, general debility, memory problems and gynaecology segment. We have strong product pipeline for male and female reproductory area and also developing natural products for many lifestyle disorders. Research is underway on herbal beverages too," Reddy added.

Marketing channels

In the domestic market, company markets Bio-Rhythm through the over the counter (OTC) route and this product is available in all leading chemist shops in Hyderabad and Secunderabad. The company will be launching these products in a phase wise manner in all South Indian states and metros across India. Preparations are underway to launch a specialised product for females as well, according to the spokesperson.

In the future

Giving details of future plans, the spokesperson reveals, "We are coming up with Phase II manufacturing and extraction facility with capacity of 100 MT/Month inclusive of Super Critical Fluid Extraction Unit, Beverage and Bottle filling unit and Formulation and Finished Product unit (Capsule and Tablet Making facilities). The Phase-II neutraceutical unit expected by the next financial year would be producing state of the art standardised herbal extracts, formulations and beverages for global markets. These products will be marketed in India through our existing network, joint ventures and also through private labelling."